Allied Market Research
Loading...
0
New
New
2021
Advanced Clinical Decision Support Platforms Market

Advanced Clinical Decision Support Platforms Market by Type (Therapeutic and Diagnostic), Model (Knowledge based and Non-Knowledge based), and Setting (Hospitals and Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13100
Pages: 190
Aug 2021 | 143 Views
   
Author(s) : Smita Nerkar , Onkar Sumant
Tables: 113
Charts: 37
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Advanced Clinical Decision Support Platforms Market

Request Now !

The advanced clinical decision support platforms market size was valued at $450.4 million in 2020, and is projected to reach 1,049.8 million by 2030, registering a CAGR of 8.70% from 2020 to 2030.Advanced clinical decision support platform provides legal information for improving the decision making abilities of the health professionals. It provides clinicians, staff, patients or other individuals with knowledge and person-specific information, intelligently filtered or presented at appropriate times, to improve health and health care. CDS encompasses a variety of tools to enhance decision-making in the clinical workflow. Furthermore, these tools include computerized alerts and reminders to care providers and patients; clinical guidelines; condition-specific order sets; diagnostic support, focused patient data reports and summaries; documentation templates and contextually relevant reference information, among other tools.

Clinical decision support platform (CDSS) technology is still in its early phase, doctors, patients, and other stakeholders will be required to offer continual input in order to effectively integrate CDSS technology in order to enhance relevant applications, decrease costs, and improve treatment outcomes, thus significantly boosting the market growth. The rise in the elderly population, increase in the number of hospitals, growth in need for data-driven technologies, and the number of emergency department (ED) visits are the main drivers for the market expansion. In the coming years, the healthcare system is projected to face a physician shortage, necessitating the use of decision-making technologies to efficiently manage physician time and prevent errors.

Advanced-Clinical-Decision-Support-Platforms-Market-2021-2030

Get more information on this report : Request Sample Pages

Rise in geriatric population leads to rise in chronic diseases, increased health assessments, rise in number of hospitals, rise in medical errors, growing demand for data driven technologies, number of emergency department (ED) visits. The healthcare system is also expected to witness shortage of physicians in the upcoming years; thus, enhancing the need of decision making tools in order to effectively manage physician time and prevent the overcrowding of hospitals due to increased medical needs. It has significantly improved the clinical results and facilitated reduction in healthcare costs, thus further boosting the market growth. Despite the advantages of the clinical decision support platforms, there are certain factors that may restrain the market growth such as the adoption rate of these tools is modest due to implementation problems. Furthermore, physicians view CDSS technologies as a threat to their professional autonomy. 

Also, COVID-19 pandemic has created new challenges in the health-care ecosystem. Huge growth in the number of critically sick patients as well as personnel shortages and capacity constraints, challenge hospitals and health systems. It has directly led to the rise in usage of CDSS tools for immediate medical treatment with fast diagnosis. The increased usage of clinical decision support software in COVID-19 has emphasized the global need for uniform healthcare data while shortening decision-making timelines owing to excessive stress. Many health care providers have altered their clinical decision support system vendors to get the desired outcomes quickly.

Advanced Clinical Decision Support Platforms Market Segmentation  

The advanced clinical decision support platforms market is segmented on the basis is segmented on the basis of type, application, setting and region. By type, it is bifurcated into therapeutic and diagnostic, the diagnostic type dominates the type segment and is most commonly used. By model, it is bifurcated into Knowledge base and Non-Knowledge based. By setting type it is bifurcated into hospitals and ambulatory care. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Advanced Clinical Decision Support Platforms Market
By Type

Your browser does not support the canvas element.

Therapeutic type segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment Review

On the basis of model, the advanced clinical decision support platforms market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2020, the knowledge-based CDSS segment accounted for the largest share of the market. The large share and high growth of this segment can be attributed to the several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors as compared to non-knowledge-based systems.

Advanced Clinical Decision Support Platforms Market
By Model

Your browser does not support the canvas element.

Knowledge based segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of North America Advanced clinical decision support platforms market  

North America accounted for the largest market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to the increased in geriatric population, rise in hospitals and emergency department visits and growth in technological advancements for CDSS. In addition, Asia-Pacific is expected to witness significant growth during the forecast period, owing to the increasing population in regions such as China and India. However, LAMEA is expected to emerge as a lucrative area with maximum growth potential, due to the improvement in healthcare facilities, available disposable income, and rapid development of economic conditions.

Advanced Clinical Decision Support Platforms Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 10.60% during 2021-2030.

Get more information on this report : Request Sample Pages

The key market players profiled in the report include Allscripts Healthcare Solutions, Cerner, Epic, Elsevier B.V., IBM Watson, Meditech, NextGen Healthcare, Siemens Healthineers, Wolters Kluwer Health and Zynx Health.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global advanced clinical decision support platforms market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the advanced clinical decision support platforms market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products the market used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the advanced clinical decision support platforms market.

Key Market Segments

BY Type

  • Therapeutic
  • Diagnostic

By Model        

  • Knowledge based    
  • Non-Knowledge based    

BY SETTING

  • Hospitals
  • Ambulatory care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

CHAPTER 3:    MARKET LANDSCAPE

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets
3.2.2.    Top winning strategies

3.3.    Porter’s five force analysis
3.4.    Top player positioning, 2020
3.5.    Market dynamics

3.5.1.    Drivers

3.5.1.1.    Growing incidence of medication error
3.5.1.2.    Increase in more patient specific platforms
3.5.1.3.    Rapid increase in aging population and subsequent rise in the number of chronic diseases

3.5.2.    Restraint

3.5.2.1.    Data security concerns related to cloud based CDSS
3.5.2.2.    Increase in concerns regarding the patient data safety & security

3.5.3.    Opportunity

3.5.3.1. Emerging Countries
3.5.4.    Impact analysis

3.6.    COVID-19 impact analysis on the advanced clinical decision support platforms market

CHAPTER 4:    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Therapeutic

4.2.1.    Key market trends, growth factors, and opportunities
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis, by country

4.3.    Diagnostic

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast, by region
4.3.3.    Market analysis, by country

CHAPTER 5:    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Knowledge based

5.2.1.    Market size and forecast, by region
5.2.2.    Market analysis, by country

5.3.    Non-knowledge based

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis, by country

CHAPTER 6:    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Hospitals

6.2.1.    Market size and forecast, by region
6.2.2.    Market analysis, by country

6.3.    Ambulatory Care Settings

6.3.1.    Market size and forecast, by region
6.3.2.    Market analysis, by country

CHAPTER 7:    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION

7.1.    Overview

7.1.1.    Market size and forecast, by region

7.2.    North America

7.2.1.    Key market trends and opportunities
7.2.2.    Market size and forecast, by type
7.2.3.    Market size and forecast, by Model
7.2.4.    Market size and forecast, by setting
7.2.5.    Market size and forecast, by country

7.2.5.1.    U.S

7.2.5.1.1.    U.S. market size and forecast, by type
7.2.5.1.2.    U.S. market size and forecast, by Model
7.2.5.1.3.    U.S. market size and forecast, by setting

7.2.5.2.    Canada

7.2.5.2.1.    Canada market size and forecast, by type
7.2.5.2.2.    Canada market size and forecast, by Model
7.2.5.2.3.    Canada market size and forecast, by setting

7.2.5.3.    Mexico

7.2.5.3.1.    Mexico market size and forecast, by type
7.2.5.3.2.    Mexico market size and forecast, by Model
7.2.5.3.3.    Mexico market size and forecast, by setting

7.3.    Europe

7.3.1.    Key market trends and opportunities
7.3.2.    Market size and forecast, by type
7.3.3.    Market size and forecast, by Model
7.3.4.    Market size and forecast, by setting
7.3.5.    Market size and forecast, by country

7.3.5.1.    Germany

7.3.5.1.1.    Germany market size and forecast, by type
7.3.5.1.2.    Germany market size and forecast, by Model
7.3.5.1.3.    Germany market size and forecast, by setting

7.3.5.2.    France

7.3.5.2.1.    France market size and forecast, by type
7.3.5.2.2.    France market size and forecast, by Model
7.3.5.2.3.    France market size and forecast, by setting

7.3.5.3.    UK

7.3.5.3.1.    UK market size and forecast, by type
7.3.5.3.2.    UK market size and forecast, by Model
7.3.5.3.3.    UK market size and forecast, by setting

7.3.5.4.    Italy

7.3.5.4.1.    Italy market size and forecast, by type
7.3.5.4.2.    Italy market size and forecast, by Model
7.3.5.4.3.    Italy market size and forecast, by setting

7.3.5.5.    Spain

7.3.5.5.1.    Spain market size and forecast, by type
7.3.5.5.2.    Spain market size and forecast, by Model
7.3.5.5.3.    Spain market size and forecast, by setting

7.3.5.6.    Rest of Europe

7.3.5.6.1.    Rest of Europe market size and forecast, by type
7.3.5.6.2.    Rest of Europe market size and forecast, by Model
7.3.5.6.3.    Rest of Europe market size and forecast, by setting

7.4.    Asia-Pacific

7.4.1.    Key market trends and opportunities
7.4.2.    Market size and forecast, by type
7.4.3.    Market size and forecast, by Model
7.4.4.    Market size and forecast, by setting
7.4.5.    Market size and forecast, by country

7.4.5.1.    Japan

7.4.5.1.1.    Japan market size and forecast, by type
7.4.5.1.2.    Japan market size and forecast, by Model
7.4.5.1.3.    Japan market size and forecast, by setting

7.4.5.2.    China

7.4.5.2.1.    China market size and forecast, by type
7.4.5.2.2.    China market size and forecast, by Model
7.4.5.2.3.    China market size and forecast, by setting

7.4.5.3.    India

7.4.5.3.1.    India market size and forecast, by type
7.4.5.3.2.    India market size and forecast, by Model
7.4.5.3.3.    India market size and forecast, by setting

7.4.5.4.    Australia

7.4.5.4.1.    Australia market size and forecast, by type
7.4.5.4.2.    Australia market size and forecast, by Model
7.4.5.4.3.    Australia market size and forecast, by setting

7.4.5.5.    South Korea

7.4.5.5.1.    South Korea market size and forecast, by type
7.4.5.5.2.    South Korea market size and forecast, by Model
7.4.5.5.3.    South Korea market size and forecast, by setting

7.4.5.6.    Rest of Asia-Pacific

7.4.5.6.1.    Rest of Asia-Pacific market size and forecast, by type
7.4.5.6.2.    Rest of Asia-Pacific market size and forecast, by Model
7.4.5.6.3.    Rest of Asia-Pacific market size and forecast, by setting

7.5.    LAMEA

7.5.1.    Key market trends and opportunities
7.5.2.    Market size and forecast, by type
7.5.3.    Market size and forecast, by Model
7.5.4.    Market size and forecast, by setting
7.5.5.    Market size and forecast, by country

7.5.5.1.    Brazil

7.5.5.1.1.    Brazil market size and forecast, by type
7.5.5.1.2.    Brazil market size and forecast, by Model
7.5.5.1.3.    Brazil market size and forecast, by setting

7.5.5.2.    Saudi

7.5.5.2.1.    Saudi market size and forecast, by type
7.5.5.2.2.    Saudi market size and forecast, by Model
7.5.5.2.3.    Saudi market size and forecast, by setting

7.5.5.3.    South Africa

7.5.5.3.1.    South Africa market size and forecast, by type
7.5.5.3.2.    South Africa market size and forecast, by Model
7.5.5.3.3.    South Africa market size and forecast, by setting

7.5.5.4.    Rest of LAMEA

7.5.5.4.1.    Rest of LAMEA market size and forecast, by type
7.5.5.4.2.    Rest of LAMEA market size and forecast, by Model
7.5.5.4.3.    Rest of LAMEA market size and forecast, by setting

CHAPTER 8:    COMPANY PROFILES

8.1.    ALLSCRIPTS HEALTHCARE SOLUTIONS INC.

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Operating business segments
8.1.4.    Product portfolio
8.1.5.    Business performance
8.1.6.    Key strategic moves and developments

8.2.    CERNER CORPORATION

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product portfolio
8.2.5.    Business performance
8.2.6.    Key strategic moves and developments

8.3.    RELX GROUP (ELSEVIER B.V.)

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio
8.3.5.    Business performance

8.4.    EPIC SYSTEM CORPORATION

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product portfolio
8.4.5.    Key strategic moves and developments

8.5.    IBM WATSON HEALTH

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Product portfolio
8.5.5.    Business performance
8.5.6.    Key strategic moves and developments

8.6.    MEDITECH

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product portfolio

8.7.    NEXTGEN HEALTHCARE, INC.

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Product portfolio
8.7.5.    Business performance
8.7.6.    Key strategic moves and developments

8.8.    SIEMENS HEALTHINEERS AG

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product portfolio
8.8.5.    Business performance
8.8.6.    Key strategic moves and developments

8.9.    WOLTERS KLUWER HEALTH

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product portfolio
8.9.5.    Business performance
8.9.6.    Key strategic moves and developments

8.10.    ZYNX HEALTH

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product portfolio

LIST OF TABLES

TABLE 01.    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.    THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS DIAGNOSTIC  MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.    GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2020–2030 ($MILLION)
TABLE 05.    KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.    NON-KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 07.    GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTINGS, 2020–2030 ($MILLION)
TABLE 08.    HOSPITALS ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 09.    AMBULATORY CARE SETTING ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 10.    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY REGION, 2020-2030, ($MILLION)
TABLE 11.    NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 12.    NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 13.    NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 14.    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 15.    U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 16.    U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 17.    U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 18.    CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 19.    CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 20.    CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 21.    MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 22.    MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 23.    MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 24.    EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 25.    EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 26.    EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 27.    EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 28.    GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 29.    GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 30.    GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 31.    FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 32.    FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 33.    FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 34.    UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 35.    UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 36.    UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 37.    ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 38.    ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 39.    ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 40.    SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 41.    SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 42.    SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 43.    REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 44.    REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 45.    REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 46.    ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 47.    ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 48.    ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 49.    ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 50.    JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 51.    JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 52.    JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 53.    CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 54.    CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 55.    CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 56.    INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 57.    INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 58.    INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 59.    AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 60.    AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 61.    AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 62.    SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 63.    SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 64.    SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 65.    REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 66.    REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 67.    REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 68.    LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 69.    LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 70.    LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 71.    LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 72.    BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 73.    BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 74.    BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 75.    SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 76.    SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 77.    SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 78.    SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 79.    SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 80.    SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 81.    REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 82.    REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 83.    REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 84.    ALLSCRIPTS: COMPANY SNAPSHOT
TABLE 85.    ALLSCRIPTS: OPERATING SEGMENTS
TABLE 86.    ALLSCRIPTS: PRODUCT PORTFOLIO
TABLE 87.    CERNER: COMPANY SNAPSHOT
TABLE 88.    CERNER: OPERATING SEGMENTS
TABLE 89.    CERNER: PRODUCT PORTFOLIO
TABLE 90.    RELX: COMPANY SNAPSHOT
TABLE 91.    RELX: OPERATING SEGMENTS
TABLE 92.    RELX: PRODUCT PORTFOLIO
TABLE 93.    EPIC SYSTEMS: COMPANY SNAPSHOT
TABLE 94.    EPIC SYSTEMS: OPERATING SEGMENTS
TABLE 95.    EPIC SYSTEMS: PRODUCT PORTFOLIO
TABLE 96.    WATSON: COMPANY SNAPSHOT
TABLE 97.    WATSON: OPERATING SEGMENTS
TABLE 98.    WATSON: PRODUCT PORTFOLIO
TABLE 99.    MEDITECH: COMPANY SNAPSHOT
TABLE 100.    MEDITECH: OPERATING SEGMENTS
TABLE 101.    MEDITECH: PRODUCT PORTFOLIO
TABLE 102.    NEXTGEN: COMPANY SNAPSHOT
TABLE 103.    NEXTGEN: OPERATING SEGMENTS
TABLE 104.    NEXTGEN: PRODUCT PORTFOLIO
TABLE 105.    SIEMENS: COMPANY SNAPSHOT
TABLE 106.    SIEMENS: OPERATING SEGMENTS
TABLE 107.    SIEMENS: PRODUCT PORTFOLIO
TABLE 108.    WOLTERS KLUWER: COMPANY SNAPSHOT
TABLE 109.    WOLTERS KLUWER: OPERATING SEGMENTS
TABLE 110.    WOLTERS KLUWER: PRODUCT PORTFOLIO
TABLE 111.    ZYNX HEALTH: COMPANY SNAPSHOT
TABLE 112.    ZYNX HEALTH: OPERATING SEGMENTS
TABLE 113.    ZYNX HEALTH: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS
FIGURE 03.    TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.    TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05.    TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.    MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.    MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.    MODERATE THREAT OF SUBSTITUTES
FIGURE 09.    MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.    MODERATE COMPETITIVE RIVALRY
FIGURE 11.    TOP PLAYER POSITIONING, 2020
FIGURE 12.    IMPACT ANALYSIS
FIGURE 13.    COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS THERAPEUTIC MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.    COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS DIAGNOSTIC MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.    COMPARATIVE ANALYSIS OF KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.    COMPARATIVE ANALYSIS OF NON-KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.    COMPARATIVE ANALYSIS OF HOSPITALS ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.    COMPARATIVE ANALYSIS OF AMBULATORY CARE SETTING ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.    ALLSCRIPTS: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.    ALLSCRIPTS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21.    ALLSCRIPTS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 22.    CERNER: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.    CERNER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.    RELX: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.    RELX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.    RELX: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.    WATSON: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.    WATSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.    WATSON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.    NEXTGEN: NET SALES, 2018-2020, ($MILLION)
FIGURE 31.    NEXTGEN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.    SIEMENS: NET SALES, 2018–2020, ($MILLION)
FIGURE 33.    SIEMENS: REVENUE SHARE BY SEGMENT, 2020, ($MILLION)
FIGURE 34.    SIEMENS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.    WOLTERS KLUWER: NET SALES, 2018–2020, ($MILLION)
FIGURE 36.    WOLTERS KLUWER: REVENUE SHARE BY SEGMENT, 2020, ($MILLION)
FIGURE 37.    WOLTERS KLUWER: REVENUE SHARE BY REGION, 2020 (%)

 
 

Rise in geriatric population, the growing number of deaths caused by medical errors, evolving reimbursement methods, rising need for data-driven technologies, increase in number of emergency department (ED) visits are the main factors for the growth of the market. Healthcare delivery framework in the industry has significantly changed and tools based on CDSS technology are enhancing the clinical performance. Furthermore, the increase in global population has led to decrease in the ratio of individuals to that of the physicians.

Increase in incidences of chronic diseases, CDSS helps in the prevention of deterioration, which can lead to unnecessary readmissions. This is especially beneficial for people who have chronic illnesses. Hospitals and health systems now have additional tools to assist clinical decision-making and potentially save millions of dollars in post-discharge patient management owing to sophisticated CDSS platforms. The pandemic of COVID-19 has posed additional problems to the health-care sector. Hospitals and health systems are being challenged by an increase in the number of critically ill patients, as well as manpower shortages and capacity restrictions. It has resulted in an increase in the use of CDSS tools for urgent medical treatment and diagnosis. Furthermore, developing separate versions of CDSS in numerous languages is a great approach for a company to investigate different prospects in different parts of the world.

Furthermore, there have been significant technological advancements in the technology like use of sensor data and mobile technology for providing clinical decision support platforms. High investments by manufacturers to upgrade CDSS tools, need of clinical decision assistance in forms that make important data easily accessible, at the same time workflow integration has been the major driving factor for the expansion of advanced clinical decision support platforms market.

North America accounted for the largest share in 2020 and is anticipated to maintain its lead during the forecast period 2020 to 2030. However, Asia-Pacific exhibits the highest growth rate, as the mean age of the global population is drifting toward older age category and LAMEA is expected to grow due to increase in private healthcare expenditure.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Advance Clinical Decision Support Platform market is $450.4 million in 2020.

A. The forcast period for Advance Clinical Decision Support Platform market is 2021 to 2030

A. The market value of Advance Clinical Decision Support Platform market in 2021 is $494.5million.

A. The base year is 2020 in Advance Clinical Decision Support Platform market

A. Top companies such as Allscripts Healthcare Solutions, Cerner, Epic, Elsevier B.V., IBM Watson, Meditech, NextGen Healthcare, Siemens Healthineers, Wolters Kluwer Health and Zynx Health held a high market position in 2020.

A. On the basis of the model, the market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2020, the knowledge-based CDSS segment accounted for the largest share of of the market. The large share and high growth of this segment can be attributed to the several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties.

A. Rise in geriatric population as it leads to rise in chronic diseases, increased health assesments, rise in number of hospitals, rise in medical errors, growing demand for data driven technologies, number of emergency department (ED) visits also boost the Advance Clinical Decision Support Platform market growth

A. North America accounted for the largest market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to the increased in geriatric population, rise in hospitals and emergency department visits and growth in technological advancements for CDSS.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Advanced Clinical Decision Support Platforms Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers